Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer.

Pathologie-biologie - 1 Dec 2013

Marchoudi N, Amrani Hassani Joutei H, Jouali F, Fekkak J, Rhaissi H

Abstract excerpt

Targeted therapies have an increasing importance in digestive oncology. To our knowledge, we are the first to report the distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer (CRC) in order to introduce targeted therapy in the arsenal of therapeutic modalities for management of this cancer in Morocco. In this study, 92 samples obtained from patients with CRC were tested for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Neoplasm
Share to ErbB Receptors
Share to Morocco

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 23849768
DOI: 10.1016/j.patbio.2013.05.004

Genes

KRAS
BRAF
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer.PMID 23849768Read ↗

Prevalence and Patterns of Mutations in RAS/RAF/MEK/ERK/MAPK Signaling Pathway in Colorectal Cancer in North AfricaSemantic proximity Read ↗

KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients.Semantic proximity Read ↗

Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa.Semantic proximity Read ↗

Correlation between KRAS and NRAS mutational status and clinicopathological features in 414 cases of metastatic colorectal cancer in Morocco: the largest North African case series.Semantic proximity Read ↗

Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.Semantic proximity Read ↗

Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.Semantic proximity Read ↗

KRAS Mutation: Characterization and Its Impact on Survival Outcome of Patients with Metastatic Colorectal Cancer.Semantic proximity Read ↗

Differences in anatomoclinical profiles between RAS-Mutated and Wild-Type colorectal cancers in an Eastern Algerian Cohort.Semantic proximity Read ↗

KRAS and BRAF mutational status in colon cancer from Albanian patients.Semantic proximity Read ↗

Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer.Semantic proximity Read ↗

Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran.Semantic proximity Read ↗

Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.